-930.67
75,364.69
-1.22%
Market Closed
1,204.7
-3.52%
1,817
1.3%
-104.45
3,299.45
-3.07%
1,741.85
-0.22%
1,334.05
0.38%
-11.4
767.8
-1.46%
-44.7
1,452.3
-2.99%
8,720.85
1.43%
2,244.45
-0.03%
0.25
409.55
0.06%
792
-2.84%
3,259.2
-4.67%
2,131
-0.04%
1,709.4
-3.43%
1,425.3
-3.09%
11,481.5
-1.72%
350.85
-2.23%
11,490
-1.01%
1,089.5
-0.02%
2,606
-0.25%
1,913
-0.41%
-17.35
226
-7.13%
4,236.5
-1.92%
293.8
-1.79%
3,081.25
-1.44%
2,338
-3.06%
4,039
-2.82%
-10.15
246.25
-3.96%
1,148.55
-4.38%
1,014.5
-2.72%
385.25
-2.98%
613.85
-6.15%
2,355.05
0.27%
17.8
2,264.95
0.79%
-213.65
7,700
-2.7%
532.5
0.74%
280.1
-2.59%
210.65
-0.09%
-115.35
5,561.25
-2.03%
5,096
1.84%
130.15
-0.65%
535
-1.74%
427.05
-7.04%
2,613
-1.5%
-308.3
4,939.8
-5.87%
140.45
-8.59%
124.9
-3.29%
-25.9
654.1
-3.81%
-37.95
401.6
-8.63%
1,512.45
-1.82%
-930.67
75364.69
-1.22%
Market Closed

CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days
The Indian Hotels Company Ltd. 24/08/2023401.85517.9007/02/2024 28.88% 167 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Sun Pharma share price slips 2 per cent post settlement order by SEBI

DSIJ Intelligence 0 2001 Article rating: 4.4

The shares of the drug manufacturer, Sun Pharmaceutical Industries Ltd had initially touched its 52-week high during the early trade on Friday but soon, slipped by almost 2 per cent after Securities & Exchange Board of India (SEBI) issued an order for settling charges made by a whistleblower.  

Alembic Pharma subsidiary secures USFDA accelerated approval for its partnered asset, Umbralisib

DSIJ Intelligence 0 1775 Article rating: 5.0

Rhizen Pharmaceuticals, a clinical-stage oncology-focussed biopharmaceutical company and subsidiary of Alembic Pharma announced that its novel next-generation PI3K-delta inhibitor, Umbralisib, which was licensed to TG Therapeutics, has secured USFDA accelerated approval.  

Dr. Reddy launches Guaifenesin and Pseudoephedrine

DSIJ Intelligence 0 3357 Article rating: 5.0

Dr. Reddy's Laboratories has launched an over-the-counter (OTC) store-brand equivalent of Mucinex D Extended-Release Tablets in two strengths-Guaifenesin 600 mg and Pseudoephedrine HCI 60 mg, and Guaifenesin 1200 mg and Pseudoephedrine HCI 120 mg in the United States market, as approved by the US Food and Drug Administration (USFDA).


Markets shine with metals

DSIJ Intelligence 0 1105 Article rating: 5.0

Benchmark indices were moving upward in the morning session on Wednesday. This was a broad based upmove with good participation from mid-cap and small-cap stocks. The market seemed to be reacting to global cues wherein the US markets gained on the back of good earnings and scheduled US Fed's policy meet.

Results Q3FY19: Review of banking sector

DSIJ Intelligence 0 1337 Article rating: 5.0

The result’s season creates quite a buzz in the market. Everyone even remotely related to the market keenly waits and watches. The Q3FY19 result season has welcomed us into the year of 2019. As the results are still coming in, let us give you a snapshot of what happened to the banks both private and public that have posted their December end results up until January 29, 2019.

 

Shaktikanta Das replaces Urjit Patel as the new RBI governor

DSIJ Intelligence 0 1366 Article rating: 5.0

The government appointed Shaktikanta Das as the new governor of the Reserve Bank of India for three years, making him the 25th RBI chief. The decision was made 24 hours after Urjit Patel’s unforeseen resignation. The swift decision is a mark of the government’s resolve to combat uncertainty.

RSS
1345678910Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR